We are live on ! Find out more
AC

Aristides Capital Portfolio holdings

AUM $462M
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+9.22%
1 Year Est. Return
+28.94%
3 Year Est. Return
+109.78%
5 Year Est. Return
+150.66%
10 Year Est. Return
AUM
$274M
AUM Growth
+$43.6M
Cap. Flow
+$36M
Cap. Flow %
13.16%
Top 10 Hldgs %
42.67%
Holding
311
New
129
Increased
29
Reduced
24
Closed
32

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$8.65M
2
TSLA icon
Tesla
TSLA
+$7.13M
3
DAL icon
Delta Air Lines
DAL
+$3.88M
4
MSFT icon
Microsoft
MSFT
+$3.31M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$2.15M

Sector Composition

Rank Sector Weight
1 Technology 11.61%
2 Consumer Discretionary 11.06%
3 Industrials 8.28%
4 Communication Services 7.13%
5 Financials 6.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENLC
176
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$240K 0.09%
19,743
VIR icon
177
Vir Biotechnology
VIR
$1.48B
$239K 0.09%
+23,743
New +$217K
XPRO icon
178
Expro Ltd
XPRO
$1.78B
$236K 0.09%
+14,803
New +$256K
AVXL icon
179
CALL
Anavex Life Sciences
AVXL
$232M
$233K 0.09%
+25,000
New +$172K
CERS icon
180
Cerus
CERS
$615M
$231K 0.08%
+106,962
New +$176K
BBW icon
181
Build-A-Bear
BBW
$428M
$230K 0.08%
10,000
ADTN icon
182
Adtran
ADTN
$769M
$227K 0.08%
+30,945
New +$204K
PL icon
183
Planet Labs
PL
$7.48B
$226K 0.08%
+91,557
New +$217K
NTCT icon
184
NETSCOUT
NTCT
$2.91B
$226K 0.08%
+10,275
New +$230K
FLNA
185
Filana Therapeutics
FLNA
$43.5M
$225K 0.08%
+10,000
New +$211K
AMWL icon
186
American Well
AMWL
$185M
$224K 0.08%
+7,526
New +$185K
OCUL icon
187
Ocular Therapeutix
OCUL
$1.89B
$224K 0.08%
+50,226
New +$149K
ELMD icon
188
Electromed
ELMD
$330M
$223K 0.08%
20,400
CENT icon
189
Central Garden & Pet Co
CENT
$2.71B
$221K 0.08%
7,038
STRO icon
190
Sutro Biopharma
STRO
$398M
$217K 0.08%
+5,048
New +$160K
FICO icon
191
Fair Isaac
FICO
$29.7B
$215K 0.08%
+185
New +$186K
SGA icon
192
Saga Communications
SGA
$54.3M
$214K 0.08%
9,630
AWRE icon
193
Aware
AWRE
$24M
$213K 0.08%
128,468
-7,261
-5% -$10.9K
VKQ icon
194
Invesco Municipal Trust
VKQ
$540M
$213K 0.08%
+22,300
New +$197K
SMMT icon
195
Summit Therapeutics
SMMT
$10.5B
$210K 0.08%
+80,601
New +$166K
CE icon
196
Celanese
CE
$4.87B
$209K 0.08%
+1,347
New +$176K
SILC icon
197
Silicom
SILC
$226M
$208K 0.08%
11,500
TSE
198
DELISTED
Trinseo
TSE
$205K 0.07%
+24,498
New +$164K
VCV icon
199
Invesco California Value Municipal Income Trust
VCV
$516M
$205K 0.07%
+20,884
New +$186K
AWI icon
200
Armstrong World Industries
AWI
$7.05B
$202K 0.07%
+2,053
New +$170K

Similar funds

Aristides Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Aristides Capital held 311 positions worth $274M, up 19% from $230M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Aristides Capital deployed $36M of net new capital in Q4 2023, opening 129 new positions and adding to 29 existing holdings. Its largest new stake was Invesco QQQ Trust: 22,780 shares worth $9.33M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was SP Plus Corporation, an estimated $1.73M trimmed.

  • Aristides Capital's largest Q4 2023 buy was Invesco QQQ Trust: 22,780 shares worth $9.33M.
  • Aristides Capital added most to Microsoft in Q4 2023, an estimated $3.31M increase.
  • Aristides Capital's biggest Q4 2023 reduction was SP Plus Corporation, cutting an estimated $1.73M.
  • Aristides Capital fully exited Center Coast Brookfield MLP & Energy Infrastructure Fund in Q4 2023, selling an estimated $3.62M.
  • Aristides Capital's ten largest holdings make up 43% of its $274M portfolio in Q4 2023.
  • Aristides Capital opened 129 new positions and closed 32 in Q4 2023.
  • Aristides Capital's portfolio value rose 19% quarter-over-quarter to $274M.

Based on Aristides Capital's 13F filing for Q4 2023, filed 13 Feb 2024.